Skip to main content
letter
. 2016 Apr 12;3:8. doi: 10.1186/s40673-016-0046-2

Fig. 1.

Fig. 1

Percent change of the coefficient of variation (CV) of stride time under continuous treatment with Acetyl-DL-leucine. Legend: Scatter plot with individual courses of temporal gait variability before and under treatment with Acetyl-DL-leucine.14 patients showed a reduction of CV of stride time by 36 % during 1-2 weeks of treatment (1-2 weeks) and 49 % during > 4 weeks of treatment